Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 81 clinical trials
MetfOrmin BenefIts Lower Extremities With Intermittent Claudication (MOBILE IC)

, predominantly to the legs, and results in intermittent claudication (IC) or recurrent muscle pain with activity secondary to insufficient blood supply. Those with PAD and IC experience a progressive decline in

  • 0 views
  • 28 Jul, 2022
  • 1 location
Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC

This study will investigate the efficacy of G-CSF mobilized mononuclear cell injection of patients with PAD who presented with intermittent claudication. Forty PAD patients who presented with

intermittent claudication
g-csf
arterial occlusive disease
  • 46 views
  • 14 Feb, 2022
  • 1 location
High Intensity Interval Training In pATiEnts With Intermittent Claudication (INITIATE)

This INITIATE study evaluates the use of high-intensity interval training as a treatment modality for patients with intermittent claudication - an ambulatory leg pain caused by narrowed arteries

intermittent claudication
leg pain
  • 53 views
  • 14 Feb, 2022
  • 1 location
  • 0 views
  • 23 May, 2022
  • 1 location
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication

This study will focus on people with claudication from peripheral arterial disease. The investigators are researching whether a multicomponent therapeutic can increase the production of Nitric

intermittent claudication
pain-free
arterial disease
cilostazol
  • 0 views
  • 25 Oct, 2021
  • 1 location
VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.

events is increased in this population. Intermittent claudication is defined as a discomfort and/or pain in the legs during walking. It is the most common clinical feature of PAD. In claudication

  • 0 views
  • 13 Dec, 2021
  • 2 locations
An E-health Intervention for Patients With Peripheral Artery Disease

The specific study aim is to determine whether a 12-week digitally delivered behavior change intervention for patients with peripheral artery disease increases walking ability, reduces smoking, improves quality of life and improves medication adherence. The primary and secondary endpoints will primarily be captured at a 12 weeks follow-up visit, but …

  • 0 views
  • 17 Nov, 2021
  • 5 locations
The Effects of Claudication Severity on Functional Outcomes

Peripheral artery disease (PAD) affects over 236 million people globally. A classic symptom of PAD is intermittent claudication (IC) which is associated with reductions in physical function. The

  • 0 views
  • 13 Aug, 2021
  • 1 location
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

The study is designed to evaluate the bioequivalence and the within-subject variability between the test formulation of extended-release tablet of cilostazol (PMR) administered once daily and the reference formulation of immediate- release tablet of cilostazol (Cilostazol) administered twice-daily in normal healthy male and female subjects under fasting conditions.

Accepts healthy volunteers
  • 0 views
  • 21 Jul, 2022
  • 1 location
Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions (TOCAF)

This is a common care study. A study for evaluating the quality of balloon inflation and stent application will be performed in 2D angiography alone in the control group and then by 2D and OCT angiography for the experimental group. The benefit could be an improvement in the results of …

angiography
  • 0 views
  • 02 Jun, 2022
  • 1 location